Related Experiment Video

Updated: Jul 13, 2026

Quantitative Detection of DNA-Protein Crosslinks and Their Post-Translational Modifications
10:12

Quantitative Detection of DNA-Protein Crosslinks and Their Post-Translational Modifications

Published on: April 21, 2023

DBC2 resistance is achieved by enhancing 26S proteasome-mediated protein degradation

Denise Collado1, Takashi Yoshihara, Masaaki Hamaguchi

  • 1Department of Biological Sciences, Fordham University, 441 E Fordham Road, Larkin Hall, Bronx, NY 10458, USA.

Biochemical and Biophysical Research Communications
|July 10, 2007
PubMed

Insights

Tumor suppressor gene DBC2 halts tumor growth by regulating CCND1. Resistant cells evade DBC2

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • The tumor suppressor gene DBC2 inhibits tumor cell proliferation via CCND1 regulation.
  • DBC2-resistant cells can emerge following sustained DBC2 induction.
  • Understanding resistance mechanisms is crucial for cancer therapy.

Purpose of the Study:

  • To investigate the molecular mechanisms underlying acquired resistance to DBC2 in cancer cells.
  • To compare DBC2 expression and degradation in sensitive versus resistant cell lines.

Main Methods:

  • Utilized T-47D cells, both sensitive and resistant to DBC2 induction.
  • Employed western blot analysis to detect DBC2 protein levels.
  • Verified inducible gene expression system responsiveness using GFP.
  • Assessed DBC2 protein production in resistant cells upon 26S proteasome inhibition (MG132).

Main Results:

  • DBC2 protein was highly expressed in sensitive cells but undetectable in resistant cells upon induction.
  • The inducible gene expression system was functional in both cell types.
  • MG132 treatment restored DBC2 protein production in resistant cells, indicating proteasomal degradation.

Conclusions:

  • Acquired resistance to DBC2 in T-47D cells is mediated by rapid, 26S proteasome-dependent degradation of DBC2 protein.
  • This degradation mechanism allows resistant cells to survive DBC2 induction.
  • Targeting the proteasome pathway could potentially overcome DBC2 resistance in cancer treatment.

More Related Videos

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines05:33

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

Published on: November 9, 2020

Tuning Degradation to Achieve Specific and Efficient Protein Depletion05:11

Tuning Degradation to Achieve Specific and Efficient Protein Depletion

Published on: July 20, 2019

Related Concept Videos

The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Long-patch Base Excision Repair01:02

Long-patch Base Excision Repair

Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are: